AACR 2026: A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
AACR 2026: A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients
AACR 2026: New KIR-CAR T cell therapy shows promise in multiple solid cancers
AACR 2026: Groundbreaking bowel cancer trial follow-up shows zero relapses
Measuring the ‘empty tank’: Pilot study gauges muscle energy in cancer survivors
AACR 2026: A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of unknown primary
AACR 2026: New platform uses machine learning to predict responses in patients with lung cancer
Colorectal cancer increasing among under 50s in Switzerland
AACR 2026: BCMA-directed CAR T-cell therapy may be effective against high-risk smouldering multiple myeloma
€500 billion disease burden: EU leaders urged to protect investment in cancer and cardiovascular health
AACR 2026: Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies
Breast cancer special issue spotlights AI while widening the view of precision care
Eating fruits, vegetables and whole grains may increase chance of early onset lung cancer